T/SHQAP 001.1-2024 Active Group standards

T/SHQAP 001.1-2024 Guidelines for Continuous Manufacture of Biopharmaceuticals Part 1: Raw Materials (Therapeutic Proteins)

T/SHQAP 001.1-2024 Guidelines for Continuous Manufacture of Biopharmaceuticals Part 1: Raw Materials (Therapeutic Proteins)

Publish Date: 2024-04-08 Implement Date: 2024-05-07 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/SHQAP 001.1-2024
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Biological products and blood products
ICS Name: Other standards related to pharmaceutics
Publish Date: 2024-04-08
Implement Date: 2024-05-07

Scope

Main technical content: This document proposes the general principles, process research, and production management recommendations for the continuous production of protein stock solutions prepared by engineered cells using continuous manufacturing technology. This document is applicable to the production of protein stock solutions prepared by engineered cells using continuous manufacturing technology, including full continuous production of stock solutions, continuous upstream and downstream production, continuous capture and recycle purification of downstream products, and continuous upstream and batch purification of downstream products; other processes that adopt some related technologies, such as the process of combining perfusion and supplementation with batch cultivation, should be implemented in accordance with the relevant guidelines

Development Information

Same series standard

Related Standards

Contact Us